MPZ gene variant site in Chinese patients with Charcot–Marie–Tooth disease

Charcot–Marie–Tooth disease (CMT) is a hereditary monogenic peripheral nerve disease. Variants in the gene encoding myelin protein zero (MPZ) lead to CMT, and different variants have different clinical phenotypes. A variant site, namely, c.389A > G (p.Lys130Arg), in the MPZ gene has been found in Chinese people. The pathogenicity of this variant has been clarified through pedigrees, and peripheral blood‐related functional studies have been conducted.

[1]  H. Baba,et al.  Upregulation of large myelin protein zero leads to Charcot–Marie–Tooth disease-like neuropathy in mice , 2020, Communications Biology.

[2]  Dana M. Bis-Brewer,et al.  Genetic modifiers and non-Mendelian aspects of CMT , 2020, Brain Research.

[3]  K. Mahnam,et al.  In silico and in vitro effects of the I30T mutation on myelin protein zero instability in the cell membrane , 2019, Cell biology international.

[4]  H. Doo,et al.  Aminosalicylic acid reduces ER stress and Schwann cell death induced by MPZ mutations , 2019, International journal of molecular medicine.

[5]  Wanjin Chen,et al.  Clinical and genetic investigation in Chinese patients with demyelinating Charcot‐Marie‐Tooth disease , 2018, Journal of the peripheral nervous system : JPNS.

[6]  D. Pareyson,et al.  New developments in Charcot–Marie–Tooth neuropathy and related diseases , 2017, Current opinion in neurology.

[7]  Xusheng Huang,et al.  Clinical and genetic spectra of Charcot‐Marie‐Tooth disease in Chinese Han patients , 2017, Journal of the peripheral nervous system : JPNS.

[8]  P. Ainsworth,et al.  Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis. , 2016, The Journal of molecular diagnostics : JMD.

[9]  D. Pareyson,et al.  A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b , 2016, Neuromuscular Disorders.

[10]  P. Nunes,et al.  Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review , 2016, Neuroepidemiology.

[11]  W. Ni,et al.  Clinical and genetic spectra in a series of Chinese patients with Charcot-Marie-Tooth disease. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[12]  R. Teleanu,et al.  Dejerine-Sottas syndrome with early onset in childhood , 2014, Romanian Journal of Neurology.

[13]  J. Lupski,et al.  The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy , 2014, Molecular genetics & genomic medicine.

[14]  S. Züchner,et al.  Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success , 2014, Genes.

[15]  M. Reilly,et al.  Charcot‐Marie‐Tooth disease , 2011, Journal of the peripheral nervous system : JPNS.

[16]  G. Nijpels,et al.  Sense of competence questionnaire among informal caregivers of older adults with dementia symptoms: A psychometric evaluation , 2007, Clinical practice and epidemiology in mental health : CP & EMH.

[17]  M. Shy,et al.  Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene , 2004, Neurology.

[18]  C. Wessig,et al.  Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder , 2004, The Journal of cell biology.

[19]  M. Shy,et al.  Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination , 2001, The Journal of cell biology.

[20]  G. Lemke,et al.  Isolation and analysis of the gene encoding peripheral myelin protein zero , 1988, Neuron.